🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Currently, for further improved survival outcome, new cytotoxic compounds s...
Status
Completed
Location
Severance Hospital, Yonsei University Health System, Yonsei Cancer Center
Start Date
2013-07
Trial ID
NCT02495493
Treatments Being Tested
Gastric cancer is a high incidence in Asia, and one of the leading cause of...
Status
Completed
Location
Severance Hospital, Yonsei University Health System
Start Date
2016-12-12
Trial ID
NCT03814759
Treatments Being Tested
The purpose of this study is to compare the efficacy between gemcitabine/ci...
Status
Terminated
Location
Gyeongsang University Hospital
Start Date
2010-07
Trial ID
NCT01096745
Treatments Being Tested
The purpose of this study is to assess efficacy and safety of docetaxel alo...
Status
Unknown
Location
Research Institute and Hospital, National Cancer Center Korea
Start Date
2008-11
Trial ID
NCT00980603
Treatments Being Tested
The purpose of this study is to evaluate S1 capsule plus Cisplatin as adjuv...
Status
Unknown
Location
Jun Feng Liu
Start Date
2014-12
Trial ID
NCT02223611
Treatments Being Tested
This is a prospective, open-label, multicenter, single-arm clinical study. ...
Status
Recruiting
Location
The First Affiliated Hospital of Xiamen University
Start Date
2025-07-30
Trial ID
NCT07085234
Treatments Being Tested
The purpose of this observational study is to evaluate the impact of differ...
Status
Completed
Location
Jiangsu Cancer Hospital
Start Date
2019-11-01
Trial ID
NCT07098104
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as S-1 and cisplatin, work in d...
Status
Completed
Location
Fukui Red Cross Hospital
Start Date
2004-04
Trial ID
NCT00182611
The purpose of this study is to compare the preventive effect of electroacu...
Status
Unknown
Location
Xijing Hospital
Start Date
2015-01
Trial ID
NCT02469493
Treatments Being Tested
This open-label, single-arm, multicenter, Phase 2 trial will treat at least...
Status
Completed
Location
Please contact the Merck KGaA Communication Center located in
Start Date
2011-06
Trial ID
NCT01388790